Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
AMGN compared with IKT: revenue, margins and what each company keeps, and the suppliers and customers both name
AMGN
Amgen Inc
Change
Mkt cap
Revenue
Revenue
IKT
Inhibikase Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
AMGN
Amgen Inc
vs
IKT
Inhibikase Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
AMGN
Amgen Inc
Change
460.55
▲
+0.06%
· post 460.42
Mkt cap
$249.0B
Revenue
$10.4B
Q3 FY26
Revenue
$36.8B
FY25
IKT
Inhibikase Therapeutics, Inc.
Change
1.50
▲
+4.05%
· post 1.50
Closed
Nov 6 '26
Mkt cap
$200.9M
Revenue
$79,569
Q3 FY23
Revenue
—
vs
Compare
Closed
Nov 6 '26
AMGN
Amgen Inc
vs
IKT
Inhibikase Therapeutics, Inc.
460.55
▲
+0.06%
post 460.42
Price
1.50
▲
+4.05%
post 1.50
$249.0B
Mkt cap
$200.9M
Q3 FY26
$10.4B
Revenue
$79,569
Q3 FY23
FY25
$36.8B
Revenue
—
Change
Change
AMGN
460.55
▲
+0.06%
vs
IKT
1.50
▲
+4.05%
Closed
Nov 6 '26
Co-movers
daily closes
Method
›
Moved together
AMGN
with
IKT
Uncorrelated: r 0.14 · 500D.
No shared co-movers.
AMGN, solid
IKT, hatched
r = correlation
Bar = r to r 0.75
Source: daily closes